Login / Signup

Utility of reproductive life plans in identification of potentially teratogenic medication use: A pilot study.

Natalie A Dipietro MagerCaitlin MillsApril Snelling
Published in: Birth (Berkeley, Calif.) (2017)
The reproductive life plan can be a useful tool to identify women of childbearing age who require intervention due to use of potentially teratogenic medications. Efforts are needed to ensure complete and accurate reporting of medication use in reproductive life plans, and to promote effective contraceptive use among women taking potentially teratogenic medications.
Keyphrases
  • polycystic ovary syndrome
  • randomized controlled trial
  • health insurance
  • pregnancy outcomes
  • high resolution
  • adipose tissue
  • cervical cancer screening
  • adverse drug
  • mass spectrometry